Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01526239 · ClinicalTrials.gov registry record · NA

Reminding Patients of the Important of Colorectal Cancer Screening Results in Patient-Initiated Promoting Colorectal Cancer Screening Via Colonoscopy

A NA study, sponsored by University of Oklahoma.

Completed
Registry status
NA
Development phase
274
Enrollment target

NCT01526239 is a NA study that has completed, run by University of Oklahoma. The registered enrollment target is 274 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01526239, a NA study, has completed, sponsored by University of Oklahoma.

COMPLETED
Registry status
NA
Development phase
274 participants
Enrollment target

Study Summary

Colorectal cancer is the third most common cancer diagnosed and third leading cause of cancer-related deaths in the United States for both men and women. The American Cancer Society (ACS) estimates about 108,070 new cases of colon cancer and 40,740 new cases of rectal cancer will be diagnosed, and about 49,960 deaths will occur as a result of this devastating disease in 2008. Over the last 20 years, the death rate for this cancer has been dropping as a result of screening and early detection of cancer. In 2007, ACS reported that early-stage colorectal cancer had a survival rate close to 80%, and up to 9,632 deaths could be prevented each year if eligible patients received screening when necessary. However, despite the proven efficacy of colorectal cancer (CRC) screening, only about 50% of eligible US patients are currently being screened. Specific Aims The central hypothesis of this proposal is that patient-initiated prompting of primary care physicians of the patient's interest in screening will increase referrals for CRC screening. The following three areas will be investigated during this research: 1. To determine whether a communication tool provided to patients will initiate a conversation with their primary care physicians about CRC screening, especially via colonoscopy. 2. To determine whether this tool will impact referral patterns for screening, especially, although not primarily, among poor and underserved populations. 3. To determine whether differences exist in regard to patient-physician communication patterns about screening among residents and faculties in the fields of internal medicine and family practice clinics. At the close of the investigators study, the investigators wish to organize quantifiable data demonstrating how patient-initiated prompting of primary care physicians for CRC screening increases early detection and decreases potential mortality from colorectal cancer. This data will inform a second, larger study to pursue the questions

Interventions

  • OTHER Colorectal cancer screening pamphlet

Trial Details

FieldValue
Enrollment Target 274 participants
Start Date 2008-11
Est. Completion 2010-11
Phase NA

Sponsor

University of Oklahoma

358 total trials

What the Registry Record Tells You About NCT01526239

The ClinicalTrials.gov registry entry for NCT01526239 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 274 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Colorectal cancer screening pamphlet is the first listed.

NCT01526239 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01526239 about?

NCT01526239 is a clinical study titled "Reminding Patients of the Important of Colorectal Cancer Screening Results in Patient-Initiated Promoting Colorectal Cancer Screening Via Colonoscopy". Colorectal cancer is the third most common cancer diagnosed and third leading cause of cancer-related deaths in the United States for both men and women. The American Cancer Society (ACS) estimates about 108,070 new cases of colon cancer and 40,740 new cases of rectal cancer will be diagnosed, and a...

What is the current status of trial NCT01526239?

This trial is currently completed. It is a NA study. The enrollment target is 274 participants. The study started on 2008-11. Estimated completion is 2010-11.

What interventions are being tested in trial NCT01526239?

The interventions under investigation include: Colorectal cancer screening pamphlet (OTHER).

Who is sponsoring clinical trial NCT01526239?

This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.